Literature DB >> 28959115

SEMIPARAMETRIC REGRESSION ANALYSIS OF REPEATED CURRENT STATUS DATA.

Baosheng Liang1, Xingwei Tong1, Donglin Zeng2, Yuanjia Wang3.   

Abstract

In many clinical studies, patients may be asked to report their medication adherence, presence of side effects, substance use, and hospitalization information during the study period. However, the exact occurrence time of these recurrent events may not be available due to privacy protection, recall difficulty, or incomplete medical records. Instead, the only available information is whether the events of interest have occurred during the past period. In this paper, we call these incomplete recurrent events as repeated current status data. Currently, there are no valid standard methods for this kind of data. We propose to use the Andersen-Gill proportional intensity assumption to analyze such data. Specifically, we propose a maximum sieve likelihood approach for inference and we show that the proposed estimators for regression coefficients are consistent, asymptotically normal and attain semiparametric efficiency bounds. Simulation studies show that the proposed approach performs well with small sample sizes. Finally, our method is applied to study medication adherence in a clinical trial on non-psychotic major depressive disorder.

Entities:  

Keywords:  Andersen-Gill model; Current status data; Recurrent events; Semiparametric efficiency; Sieve estimation

Year:  2017        PMID: 28959115      PMCID: PMC5611822          DOI: 10.5705/ss.202014.0153

Source DB:  PubMed          Journal:  Stat Sin        ISSN: 1017-0405            Impact factor:   1.261


  9 in total

1.  Hazard regression for interval-censored data with penalized spline.

Authors:  Tianxi Cai; Rebecca A Betensky
Journal:  Biometrics       Date:  2003-09       Impact factor: 2.571

2.  Evaluation of outcomes with citalopram for depression using measurement-based care in STAR*D: implications for clinical practice.

Authors:  Madhukar H Trivedi; A John Rush; Stephen R Wisniewski; Andrew A Nierenberg; Diane Warden; Louise Ritz; Grayson Norquist; Robert H Howland; Barry Lebowitz; Patrick J McGrath; Kathy Shores-Wilson; Melanie M Biggs; G K Balasubramani; Maurizio Fava
Journal:  Am J Psychiatry       Date:  2006-01       Impact factor: 18.112

Review 3.  Sequenced Treatment Alternatives to Relieve Depression (STAR*D). Part 2: Study outcomes.

Authors:  Robert H Howland
Journal:  J Psychosoc Nurs Ment Health Serv       Date:  2008-10       Impact factor: 1.098

4.  Regression analysis of mixed recurrent-event and panel-count data.

Authors:  Liang Zhu; Xinwei Tong; Jianguo Sun; Manhua Chen; Deo Kumar Srivastava; Wendy Leisenring; Leslie L Robison
Journal:  Biostatistics       Date:  2014-03-19       Impact factor: 5.899

5.  Models for longitudinal data: a generalized estimating equation approach.

Authors:  S L Zeger; K Y Liang; P S Albert
Journal:  Biometrics       Date:  1988-12       Impact factor: 2.571

Review 6.  The development of a Clinician-Administered PTSD Scale.

Authors:  D D Blake; F W Weathers; L M Nagy; D G Kaloupek; F D Gusman; D S Charney; T M Keane
Journal:  J Trauma Stress       Date:  1995-01

Review 7.  The sequenced treatment alternatives to relieve depression (STAR*D) trial: a review.

Authors:  Mark Sinyor; Ayal Schaffer; Anthony Levitt
Journal:  Can J Psychiatry       Date:  2010-03       Impact factor: 4.356

Review 8.  The STAR*D study: treating depression in the real world.

Authors:  Bradley N Gaynes; A John Rush; Madhukar H Trivedi; Stephen R Wisniewski; Donald Spencer; Maurizio Fava
Journal:  Cleve Clin J Med       Date:  2008-01       Impact factor: 2.321

9.  Sequenced treatment alternatives to relieve depression (STAR*D): rationale and design.

Authors:  A John Rush; Maurizio Fava; Stephen R Wisniewski; Philip W Lavori; Madhukar H Trivedi; Harold A Sackeim; Michael E Thase; Andrew A Nierenberg; Frederic M Quitkin; T Michael Kashner; David J Kupfer; Jerrold F Rosenbaum; Jonathan Alpert; Jonathan W Stewart; Patrick J McGrath; Melanie M Biggs; Kathy Shores-Wilson; Barry D Lebowitz; Louise Ritz; George Niederehe
Journal:  Control Clin Trials       Date:  2004-02
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.